|
2008 Conference Publication Is depression in Parkinson’s disease ‘organic’ or ‘reactive’Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick, G. (2008). Is depression in Parkinson’s disease ‘organic’ or ‘reactive’. Australian Society for Medical Research Queensland Postgraduate Student Conference, Brisbane, Australia, 29 May 2008. |
|
2008 Conference Publication Risk factors for depression in Parkinson’s diseaseDissanayaka, N., O’Sullivan, J., Silburn, P. and Mellick, G. (2008). Risk factors for depression in Parkinson’s disease. 6th International Congress on Mental Dysfunctions and Other Non-motor Features in Parkinson’s Disease, Dresden, Germany, 16-19 October 2008. |
|
2007 Conference Publication Genetic and non-genetic determinants of depression in the setting of Parkinson's diseaseDissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick, G. (2007). Genetic and non-genetic determinants of depression in the setting of Parkinson's disease. ASMR Queensland Postgraduate Medical Research Student Conference, Brisbane, QLD, Australia, 23 May, 2007. |
|
2007 Conference Publication Increased population of activated T cells in patients after acute ischemic strokeYan, J., Greer, J. M., Cavanagh, H., Henderson, R., O'Sullivan, J., Read, S., Etherington, K. and McCombe, P. A. (2007). Increased population of activated T cells in patients after acute ischemic stroke. 37th Annual Scientific Meeting of the Australasian Society for Immunology, Sydney, Australia, 2-6 December 2007. |
|
2007 Conference Publication A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson's disease.Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick, G. (2007). A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson's disease.. 2007 Eskitis Institute Graduate Student Symposium, Brisbane, Australia, October, 2007. |
|
2007 Conference Publication What contributes to depression in the setting of Parkinson's disease?Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2007). What contributes to depression in the setting of Parkinson's disease?. 4th National Conference on Depression in the Elderly, Sydney, NSW, Australia, 28-29 June, 2007. |
|
2007 Conference Publication A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson’s diseaseDissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick G. (2007). A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson’s disease. 6th Australian Human Gene Mapping Conference, Brisbane, Australia, 29-31 August 2007. |
|
2006 Conference Publication Regular exposure to pesticides is related to depression associated with Parkinson's disease: evidence from two independent Australian samplesDissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Regular exposure to pesticides is related to depression associated with Parkinson's disease: evidence from two independent Australian samples. 2006 Eskitis Institute Graduate Student Symposium, Brisbane, QLD, Australia, November, 2006. |
|
2006 Conference Publication Regular exposure to pesticides is related to depression associated with Parkinson's Disease: evidence from two independent Australian samplesDissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Regular exposure to pesticides is related to depression associated with Parkinson's Disease: evidence from two independent Australian samples. 5th International Congress on Mental Dysfunction in Parkinson's Disease, Amsterdam, Netherlands, 12-14 June, 2006. Camden, London, United Kingdom: Elsevier. doi: 10.1016/S1353-8020(07)70104-9 |
|
2006 Conference Publication Assessing risk factors for depression in Parkinson’s diseaseDissanayaka, N., Selbach, A., Matheson, S., Marsh, R., Silburn, P. A., O'Sullivan, J. D., Byrne, G. J. and Mellick, G. D. (2006). Assessing risk factors for depression in Parkinson’s disease. 5th National Conference of Emerging Researchers in Aging, Sydney, Australia, 2006. Sydney, Australia: University of Sydney, Centre for Education and Research on Ageing. |
|
2006 Conference Publication Assessing the risk factors for depression in Parkinson's diseaseDissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Assessing the risk factors for depression in Parkinson's disease. ASMR Queensland Postgraduate Medical Research Student Conference, Brisbane, QLD, Australia, 26 May, 2006. |
|
2006 Conference Publication Validity of three depression rating scales in Australian Parkinson's Disease patientsDissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Validity of three depression rating scales in Australian Parkinson's Disease patients. 5th International Congress on Mental Dysfunction in Parkinson's Disease, Amsterdam, Netherlands, 12-14 June, 2006. Camden, London, United Kingdom: Elsevier. doi: 10.1016/S1353-8020(07)70108-6 |
|
2006 Conference Publication Validity of three depression rating scales in Australian Parkinson's disease patientsDissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Validity of three depression rating scales in Australian Parkinson's disease patients. 2006 Eskitis Institute Graduate Student Symposium, Brisbane, QLD, Australia, November, 2006. |
|
2005 Conference Publication Circadian blood pressure variation after acute strokePandian, J., Wong, A., Lincoln, D., Davis, J., Henderson, R., O'Sullivan, J. and Read, S. (2005). Circadian blood pressure variation after acute stroke. 18th World Congress of Neurology, Sydney, Australia, 5-11 November 2005. Amsterdam, Netherlands: Elsevier . |
|
2005 Conference Publication Development of a patient knowledge questionnaire for botulinum toxin use in movement disordersSchoffer, KL and O'Sullivan, JD (2005). Development of a patient knowledge questionnaire for botulinum toxin use in movement disorders. 18th World Congress of Neurology, Sydney Australia, Nov 05-11, 2005. AMSTERDAM: ELSEVIER SCIENCE BV. |
|
2005 Conference Publication The impact of depression and motor disability on quality of life in patients suffering from Parkinson's diseaseDissanayaka, N. N. W., Sellbach, A., O’Sullivan, J. D., Silburn, P. A. and Mellick, G. D. (2005). The impact of depression and motor disability on quality of life in patients suffering from Parkinson's disease. The University of Queensland School of Medicine Southern Clinical Division Post Graduate Student Conference, Brisbane, QLD, Australia, 2005. |
|
2005 Conference Publication Impact of depression on quality of life in people with Parkinson’s diseaseDissanayaka, N. N. W., Sellbach, A., O’Sullivan, J. D., Silburn, P. A. and Mellick, G. D. (2005). Impact of depression on quality of life in people with Parkinson’s disease. 4th National Conference of Emerging Researchers in Aging, Brisbane, 2005. |
|
2005 Conference Publication Risk factors and assessment methods for depression associated with Parkinson's diseaseDissanayaka, N. N. W., Deng, Y., Marsh, R., O’Sullivan, J. D., Silburn, P. A., Roberts, M. and Mellick, G. D. (2005). Risk factors and assessment methods for depression associated with Parkinson's disease. ASMR Queensland Postgraduate Medical Research Student Conference, Brisbane, QLD, Australia, 10 June, 2005. |
|
2002 Conference Publication Controlled trial of speech therapy and intra-parotid botulinum toxin for the treatment of salivary drooling in Parkinson's diseaseO'Sullivan, JD, Turner, K, Marks, L and Lees, AJ (2002). Controlled trial of speech therapy and intra-parotid botulinum toxin for the treatment of salivary drooling in Parkinson's disease. 7th International Congress of Parkinsons Disease and Movement Disorders, Miami Florida, Nov 10-14, 2002. NEW YORK: WILEY-LISS. |
|
2002 Conference Publication Dopamine transporter imaging with I-123-FP-CIT SPECT demonstrates marked presynaptic nigrostriatal dopaminergic deficit in orthostatic tremorKatzenschlager, R, Costa, D, Gerschlager, W, O'Sullivan, JD, Lees, AJ and Brown, P (2002). Dopamine transporter imaging with I-123-FP-CIT SPECT demonstrates marked presynaptic nigrostriatal dopaminergic deficit in orthostatic tremor. 7th International Congress of Parkinsons Disease and Movement Disorders, Miami Florida, Nov 10-14, 2002. NEW YORK: WILEY-LISS. |
